DCE-MRI AIF Calibration: Anatomy of a Failed Endpoint
Nine imaging centers analyzed the same prostate DCE-MRI datasets and produced substantially different pharmacokinetic results…
Bridging neuroimaging software and clinical practice.
Curated insights, technical breakdowns, and peer-reviewed updates tailored to specific domains of neuroimaging and software validation.
Nine imaging centers analyzed the same prostate DCE-MRI datasets and produced substantially different pharmacokinetic results…
A longitudinal MRI trial can look statistically reassuring and still be measuring two different instruments.
A longitudinal QSM study can fail without producing an obviously bad image. The susceptibility maps may look clean, the…
Cardiac MRI strain analysis is constrained by how the myocardium is encoded before reconstruction. Myocardial tagging writes a…
Medscape has published a piece on neurofilament light chain (NfL) as a biomarker for neurologic disease, joining a tight cluster…
Arterial spin labeling can quantify cerebral blood flow without an injected contrast agent, but the number reported by the…
A dynamic contrast-enhanced MRI examination can produce a series of images in which a tumor, organ, or lesion gradually changes…
An MRI biomarker is not validated because a model separates two labels. It is validated when the measured signal survives…
A treatment effect can appear to weaken over time even when the underlying biology has not changed. In a multi-center MRI trial…
R2* mapping and quantitative susceptibility mapping both begin with the same acquisition family: multi-echo gradient-echo MRI…
Arterial spin labeling can quantify cerebral blood flow without an injected contrast agent, but the number that emerges from an…
Two 3T scanners. The same field strength. Native T1 values that diverge by more than 60 milliseconds between sites: one machine…
A change in tumor enhancement can look persuasive on a color-coded DCE-MRI map and still be too small, too unstable, or too…
There is a particular kind of disappointment that arrives, quietly, when a longitudinal neuroimaging study is interrupted…
A QSM biomarker can look impressively stable in a phantom and still become annoyingly slippery once it enters a real multi-center…